Patents by Inventor Gary Koolpe

Gary Koolpe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20170217908
    Abstract: Benzotriazine doxides are disclosed as drugs targeting mycobacterium tuberculosis, including novel compounds of formula I:
    Type: Application
    Filed: April 11, 2017
    Publication date: August 3, 2017
    Applicant: SRI INTERNATIONAL
    Inventors: Peter Madrid, Sidharth Chopra, Kenneth Ryan, Gary Koolpe
  • Patent number: 9663478
    Abstract: Benzotriazine doxides are disclosed as drugs targeting mycobacterium tuberculosis, including novel compounds of formula I:
    Type: Grant
    Filed: December 23, 2012
    Date of Patent: May 30, 2017
    Assignee: SRI INTERNATIONAL
    Inventors: Peter Madrid, Sidharth Chopra, Kenneth Ryan, Gary Koolpe
  • Publication number: 20130150369
    Abstract: Benzotriazine doxides are disclosed as drugs targeting mycobacterium tuberculosis, including novel compounds of formula I:
    Type: Application
    Filed: December 23, 2012
    Publication date: June 13, 2013
    Applicant: SRI INTERNATIONAL
    Inventors: Peter Madrid, Sidharth Chopra, Kenneth Ryan, Gary Koolpe
  • Publication number: 20070065700
    Abstract: Sulfonated polymer compositions including a polymer or copolymer derived from the monomer 2,2?-di-(4,4?dihydroxyphenyl) pentafluoropropanesulfonic acid are provided. Such compositions can provide improved polymer electrolyte membranes, especially in preferred embodiments including polybenzimidazole and polyacrylonitrile in the composition. These membranes can provide high ion conductivity in combination with improved thermal and mechanical stability, and are especially suitable for high temperature operation. Applications of such membranes include fuel cell electrolytes, electrolyzer electrolytes and battery electrolytes.
    Type: Application
    Filed: March 30, 2006
    Publication date: March 22, 2007
    Inventors: Gary Koolpe, Susanna Ventura
  • Patent number: 6369253
    Abstract: A method is provided for synthesizing metallocene compounds useful as polymerization catalysts and the like. The method involves (a) preparation of an amino alcohol-derived ligand by reacting a silane reactant with an amino alcohol in the presence of base, followed by (b) metallation of the ligand so provided. The metallocenes may be provided in chiral form when the amino alcohol contains an asymmetric center, and are thus useful in catalyzing stereospecific polymerization and other stereospecific bond formation reactions.
    Type: Grant
    Filed: March 6, 2000
    Date of Patent: April 9, 2002
    Assignee: SRI International
    Inventors: Robert B. Wilson Jr., Gary A. Koolpe
  • Patent number: 6176984
    Abstract: High temperature polybenzazole and polyether polymer electrolytes are provided. High temperature polybenzazole polymer electrolytes may comprise a benzobisoxazole, a benzobisthiazole, a benzobisimidazole, a difluorodisulfonated phenyl ring or a sulfonated bisphenylether. High temperature polyether polymers comprise a persulfonated phenyl ring, and a substituted phenyl ring or a substituted bisphenylsulfonyl ring system.
    Type: Grant
    Filed: June 28, 1999
    Date of Patent: January 23, 2001
    Assignee: SRI International
    Inventors: Subhash Narang, Susanna Ventura, Gary Koolpe
  • Patent number: 6048992
    Abstract: A method is provided for synthesizing metallocene compounds useful as polymerization catalysts and the like. The method involves (a) preparation of an amino alcohol-derived ligand by reacting a silane reactant with an amino alcohol in the presence of base, followed by (b) metallation of the ligand so provided. The metallocenes may be provided in chiral form when the amino alcohol contains an asymmetric center, and are thus useful in catalyzing stereospecific polymerization and other stereospecific bond formation reactions.
    Type: Grant
    Filed: March 25, 1999
    Date of Patent: April 11, 2000
    Assignee: SRI International
    Inventors: Robert B. Wilson, Jr., Gary A. Koolpe
  • Patent number: 5830600
    Abstract: Novel fire-retardant electrolyte compositions are provided. These compositions comprise a lithium salt dissolved in a fire-retardant solvent selected from the group consisting of phosphates, phospholanes, cyclophosphazenes, silanes, fluorinated carbonates, fluorinated polyethers and mixtures thereof. The electrolyte composition optionally contains a CO.sub.2 -generating compound. Also provided are fire-retardant batteries and fire-retardant conductive films formulated with such compositions, as well as methods of manufacturing such films.
    Type: Grant
    Filed: May 24, 1996
    Date of Patent: November 3, 1998
    Assignee: SRI International
    Inventors: Subhash C. Narang, Susanna C. Ventura, Brian J. Dougherty, Ming Zhao, Stuart Smedley, Gary Koolpe
  • Patent number: 4925856
    Abstract: A therapeutically effective class of low toxicity aldoxime-substituted functionalized imidazolium compounds and compositions is disclosed which is effective in the treatment of living species poisoned by organophosphorus chemicals which inactivate the enzyme acetylcholinesterase. In vivo administration of therapeutically effective amounts of these aldoxime-substituted imidazolium derivatives has been found to save mammals having inhibited acetylcholinesterase due to injection with lethal dosages of Soman.
    Type: Grant
    Filed: April 19, 1989
    Date of Patent: May 15, 1990
    Assignee: SRI International
    Inventors: Ralph N. Harris, III, Clifford D. Bedford, Dane A. Goff, Duane E. Hilmas, Robert A. Howd, Richard A. Kenley, Gary A. Koolpe, Robert O. Pick
  • Patent number: 4865837
    Abstract: A therapeutically effective class of low toxicity aldoxime-substituted trazolium derivatives is disclosed which is effective in the treatment of living species poisoned by organophosphorus chemicals which inactivate the enzyme acetylcholinesterase. In vivo administration of therapeutically effective amounts of these low toxicity aldoxime-substituted triazolium derivatives has been found to save mice having inhibited acetylcholinesterase due to injection with lethal dosages of Soman.
    Type: Grant
    Filed: July 28, 1987
    Date of Patent: September 12, 1989
    Assignee: SRI International
    Inventors: Ralph N. Harris, III, Clifford D. Bedford, Duane E. Hilmas, Robert A. Howd, Richard A. Kenley, Gary A. Koolpe